文献速递主动脉疾病

当前可用腔内移植物行肾下腹主动脉瘤腔内修复术早期及随访失败形态学与临床预测因素

Morphological and Clinical Predictors of Early/Follow-up Failure of the Endovascular Infrarenal Abdominal Aneurysm Repair With Currently Available Endografts.
PubMed 文献 · J Endovasc Ther · 2023-03-04

该研究前瞻性收集2012至2020年行肾下腹主动脉瘤腔内修复术(EVAR)的患者并回顾性分析,共纳入710例。技术成功率和近端颈相关技术成功率分别为98%和99%,30天死亡6例(0.8%),随访平均53±13个月,5年免于再干预率91%、生存率74%。研究识别了与技术失败、随访期近端I型内漏、再干预和死亡相关的术前及术后危险因素。

要点

  • ≥2项不良肾下颈解剖特征与技术要求失败相关(OR 2.4,95%CI 1.3-4.1,p=0.007)。
  • 肾下颈长度<15 mm、直径>28 mm、角度≥90°及持续性II型内漏是随访期近端I型内漏的独立危险因素。
  • 随访期近端I型内漏是再干预的独立危险因素(HR 29.5,95%CI 1.4-1.6,p<0.001)。

核心结论

  • 当前可用腔内移植物行EVAR具有高技术成功率和低30天死亡率,中期生存率和免于再干预率令人满意。
  • 术前和术后技术与临床失败的危险因素已被识别,作者认为应在EVAR适应证选择和术后管理中加以考虑,以减少并发症并改善中期结局。

研究设计与样本

  • 前瞻性收集2012至2020年行肾下腹主动脉瘤EVAR的患者,并进行回顾性分析,共纳入710例。
  • 早期结局评估技术成功(无I-III型内漏、肾/腹下动脉丧失、髂支闭塞、术后24小时内转开放手术和死亡)、近端颈相关技术成功(无近端I型内漏、非计划肾动脉覆盖)和30天死亡率。
  • 随访期评估近端I型内漏、生存率和免于再干预率,采用单/多因素分析和Cox回归识别相关因素,Kaplan-Meier分析评估免于再干预率和生存率。

主要发现

  • 技术成功692例(98%),近端颈相关技术成功700例(99%),术后30天内死亡6例(0.8%)。
  • 平均随访53±13个月,随访期发生近端I型内漏12例(1.7%),5年免于再干预率91%,5年生存率74%,晚期主动脉相关死亡2例(0.3%)。
  • ≥2项不良肾下颈解剖特征与技术要求失败相关(OR 2.4,95%CI 1.3-4.1,p=0.007)。
  • 肾下颈角度>90°(OR 2.88,95%CI 9.6-50.3,p=0.004)、桶状形态(OR 2.33,95%CI 11.1-100.3,p=0.02)或≥2项不良肾下颈解剖特征(OR 2.16,95%CI 2.5-5.3,p=0.03)是颈相关技术失败的独立危险因素。
  • 慢性阻塞性肺疾病(OR 16,95%CI 1.1-218.3,p=0.04)和急诊修复(OR 15,95%CI 1.8-119.6,p=0.01)是30天死亡的独立危险因素。

关键数值与推荐

  • 随访期近端I型内漏的独立危险因素:肾下颈长度<15 mm(HR 2.8,95%CI 1.9-9.6,p=0.005)、直径>28 mm(HR 2.7,95%CI 1.6-9.5,p=0.006)、角度≥90°(HR 2.7,95%CI 8.3-50.1,p=0.007)和持续性II型内漏(HR 2.9,95%CI 1.6-10.1,p=0.004)。
  • 随访期近端I型内漏是再干预的独立危险因素(HR 29.5,95%CI 1.4-1.6,p<0.001)。
  • 随访期死亡的独立危险因素:外周动脉闭塞性疾病(HR 1.9,95%CI 1.4-3.65,p=0.03)、动脉瘤直径≥65 mm(HR 2.2,95%CI 1.4-3.26,p<0.001)和肾下颈长度<15 mm(HR 1.7,95%CI 1.2-2.35,p=0.04)。

临床怎么用

  • 作者认为,术前和术后技术与临床失败的危险因素应在EVAR适应证选择和术后管理中加以考虑,以减少并发症并改善中期结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report outcomes of endovascular repair (EVAR) of infrarenal abdominal aortic aneurysms (AAAs) with currently-available endografts and identify predictors of technical/clinical failure. MATERIALS AND METHODS: Patients undergoing EVAR between 2012 and 2020 were prospectively collected and retrospectively analyzed. Technical success (TS: no type I-III endoleaks, renal/hypogastric arteries loss, iliac leg occlusion, conversion to open repair and mortality within 24 postoperative hour), proximal neck-related TS (nr-TS: no proximal type I endoleaks, unplanned renal arteries coverage), and 30-day mortality were assessed as early outcomes. Proximal type I endoleak (ELIa), survival and freedom from reinterventions (FFRs) were assessed during follow-up. Uni/multivariate analysis and Cox-regression were used to identified factors associated with early and follow-up outcomes; FFR and survival were assessed by Kaplan-Meier analysis. RESULTS: A total of 710 were included. Technical success and nr-TS were 692 (98%) and 700 (99%), respectively. The presence of ≥2 hostile anatomical infrarenal neck characteristics was associated with technical failure (odds ratio [OR]: 2.4; 95% confidence interval [CI]: 1.3-4.1; p: 0.007). Infrarenal neck angle >90° (OR: 2.88; 95% CI: 9.6-50.3; p: 0.004), barrel shape (OR: 2.33; 95% CI: 11.1-100.3; p: 0.02) or presence of ≥2 hostile anatomical infrarenal neck characteristics (OR: 2.16; 95% CI: 2.5-5.3; p: 0.03) were independent risk factors for neck-related technical failures. Six (0.8%) patients died within 30 postoperative days. Chronic obstructive pulmonary disease (OR: 16; 95% CI: 1.1-218.3; p: 0.04) and urgent repair (OR: 15; 95% CI: 1.8-119.6; p: 0.01) were independent risk factors for 30-day mortality. The mean follow-up was 53±13 months. There were 12 (1.7%) ELIa during follow-up. Infrarenal neck length <15 mm (hazard ratio [HR]: 2.8; 95% CI: 1.9-9.6; p: 0.005), diameter >28 mm (HR: 2.7; 95% CI: 1.6-9.5; p: 0.006), angle ≥90° (HR: 2.7; 95% CI: 8.3-50.1; p: 0.007), and persistent type II endoleak (HR: 2.9; 95% CI: 1.6-10.1; p: 0.004) were independent risk factors for ELIa. Freedom from reintervention was 91% at 5 years. The ELIa was an independent risk factor for reinterventions during follow-up (HR: 29.5; 95% CI: 1.4-1.6; p<0.001). Survival was 74% at 5 years with 2 cases (0.3%) of late aortic-related mortality. Peripheral arterial occlusive disease (HR: 1.9; 95% CI: 1.4-3.65; p: 0.03), aneurysm diameter ≥65 mm (HR: 2.2; 95% CI: 1.4-3.26; p<0.001), and infrarenal neck length <15 mm (HR: 1.7; 95% CI: 1.2-2.35; p: 0.04) were independent risk factors for mortality during follow-up. CONCLUSION: Endovascular repair with currently-available endografts has high TS and low 30-day mortality. Survival and FFRs were satisfactory at mid-term. Pre/postoperative risk factors for technical and clinical failure were identified and they should be considered in EVAR indication and postoperative management to reduce complications and improve mid-term outcome. CLINICAL IMPACT: Pre and postoperative risk factors for technical and clinical EVAR failure can be identified and they should be considered in EVAR indication and postoperative management to reduce complications and improve mid-term outcome.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Faggioli G, Mascoli C, et al. Morphological and Clinical Predictors of Early/Follow-up Failure of the Endovascular Infrarenal Abdominal Aneurysm Repair With Currently Available Endografts. J Endovasc Ther. 2023. PMID: 36869687. doi:10.1177/15266028231158312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。